John H. Tucker - 29 Mar 2024 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role: President and CEO, Director
Signature: /s/ John H. Tucker
Issuer symbol: SCPH
Transactions as of: 29 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 02 Apr 2024, 16:15:16 UTC
Previous filing: 22 Jan 2024
Next filing: 07 Jan 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SCPH	Stock Option (right to buy)	Award	$0	+56,025		$0.000000	56,025	29 Mar 2024	Common Stock	56,025	$7.06	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 25, 2021, the Reporting Person was granted 112,050 options which were eligible to vest and become exercisable subject to certain performance conditions. On March 29, 2024, the Issuer's Board of Directors determined that the performance conditions for one half (1/2) of the grant were met, resulting in the vesting of 56,025 shares. The remaining 56,025 options were previously forfeited due to failure to meet certain performance conditions.

Content

On January 25, 2021, the Reporting Person was granted 112,050 options which were eligible to vest and become exercisable subject to certain performance conditions. On March 29, 2024, the Issuer's Board of Directors determined that the performance conditions for one half (1/2) of the grant were met, resulting in the vesting of 56,025 shares. The remaining 56,025 options were previously forfeited due to failure to meet certain performance conditions.